Sugimoto N - Search Results

1

Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment.

Masui H, Kawada K, Itatani Y, Hirai H, Nakanishi Y, Kiyasu Y, Hanada K, Okamoto M, Hirata W, Nishikawa Y, Sugimoto N, Tamura T, Sakai Y, Obama K. Masui H, et al. Among authors: sugimoto n. Br J Cancer. 2024 Jul;131(1):63-76. doi: 10.1038/s41416-024-02710-x. Epub 2024 May 15. Br J Cancer. 2024. PMID: 38750114 Free PMC article.

2

Neutrophil Extracellular Traps Promote Metastases of Colorectal Cancers through Activation of ERK Signaling by Releasing Neutrophil Elastase.

Okamoto M, Mizuno R, Kawada K, Itatani Y, Kiyasu Y, Hanada K, Hirata W, Nishikawa Y, Masui H, Sugimoto N, Tamura T, Inamoto S, Sakai Y, Obama K. Okamoto M, et al. Among authors: sugimoto n. Int J Mol Sci. 2023 Jan 6;24(2):1118. doi: 10.3390/ijms24021118. Int J Mol Sci. 2023. PMID: 36674635 Free PMC article.

3

Downregulation of osteoprotegerin in colorectal cancer cells promotes liver metastasis via activating tumor-associated macrophage.

Hirata W, Itatani Y, Masui H, Kawada K, Mizuno R, Yamamoto T, Okamoto T, Ogawa R, Inamoto S, Maekawa H, Okamura R, Kiyasu Y, Hanada K, Okamoto M, Nishikawa Y, Sugimoto N, Tamura T, Hatano E, Sakai Y, Obama K. Hirata W, et al. Among authors: sugimoto n. Sci Rep. 2023 Dec 14;13(1):22217. doi: 10.1038/s41598-023-49312-w. Sci Rep. 2023. PMID: 38097649 Free PMC article.

4

High GRWD1 expression may predict clinically aggressive lower grade glioma, skin cutaneous melanoma, and kidney renal clear cell carcinoma carrying wild-type p53: a systematic study based on TCGA data analysis.

Kayama K, Ooga A, Hasetsu K, Kokubo R, Sugimoto N, Fujita M. Kayama K, et al. Among authors: sugimoto n. J Biochem. 2025 Jan 15:mvaf004. doi: 10.1093/jb/mvaf004. Online ahead of print. J Biochem. 2025. PMID: 39812614

5

The Efficacy of FOLFIRI Plus Ramucirumab in Recurrent Colorectal Cancer Refractory to Adjuvant Chemotherapy with Oxaliplatin/Fluoropyrimidine-Including Biomarker Analyses.

Sugimoto N, Noura S, Kato T, Yoshioka S, Hata T, Naito A, Tei M, Tamagawa H, Komori T, Ide Y, Fukuzaki T, Danno K, Sawada G, Kagawa Y, Shimokawa T, Miyoshi N, Ogino T, Uemura M, Yamamoto H, Murata K, Doki Y, Eguchi H. Sugimoto N, et al. Cancers (Basel). 2024 Dec 30;17(1):91. doi: 10.3390/cancers17010091. Cancers (Basel). 2024. PMID: 39796720 Free PMC article.

6

Salvage-line of Capecitabine Plus Oxaliplatin Therapy (XELOX) for Patients With Inoperable/Advanced Gastric Cancer Resistant/Intolerant to Cisplatin (OGSG1403).

Sugimoto N, Kawada J, Oka Y, Ueda S, Murakami K, Nishikawa K, Kurokawa Y, Fujitani K, Kawakami H, Endo S, Sakai D, Shimokawa T, Satoh T. Sugimoto N, et al. Anticancer Res. 2025 Jan;45(1):307-313. doi: 10.21873/anticanres.17418. Anticancer Res. 2025. PMID: 39740851 Clinical Trial.

7

Longitudinal changes following the introduction of socially assistive robots in nursing homes: a qualitative study with ICF framework and causal loop diagramming.

Otaka E, Sato K, Shimotori D, Ninomiya T, Sugimoto N, Nakabo Y, Matsumoto Y, Yoshida T, Kondo I. Otaka E, et al. Among authors: sugimoto n. BMC Geriatr. 2024 Dec 21;24(1):1026. doi: 10.1186/s12877-024-05628-4. BMC Geriatr. 2024. PMID: 39709345 Free PMC article.

8

[Questionnaire Survey on the Response to the Reduction of the Equivalent Dose Limit of the Crystalline Lens in the Tokai Region].

Ohsawa M, Nagata A, Saijo T, Yamada T, Sugimoto N, Tokudome A, Suzuki K, Sakamoto H. Ohsawa M, et al. Among authors: sugimoto n. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2025;81(2). doi: 10.6009/jjrt.25-1468. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2025. PMID: 39694524 Free article. Japanese.

9

Application of High-performance Liquid Chromatography to Caprolactam Migration Testing of Food Utensils, Containers, and Packaging.

Abe Y, Yamaguchi M, Fujihara K, Kataoka Y, Mutsuga M, Sugimoto N. Abe Y, et al. Among authors: sugimoto n. Shokuhin Eiseigaku Zasshi. 2024;65(5):107-112. doi: 10.3358/shokueishi.65.107. Shokuhin Eiseigaku Zasshi. 2024. PMID: 39694506 Free article.

10

Effect of obesity on pharmacokinetics of transdermal fentanyl: Single-center retrospective study and animal study.

Mizuno S, Gake S, Takabayashi M, Ito Y, Sanada H, Sugimoto N, Maeda A, Tamamura T, Sawamoto K, Hara Y, Ohi Y, Tsuji C, Shiomoto Y, Kato Y, Fujita A, Shimada T, Miyamoto KI, Sai Y. Mizuno S, et al. Among authors: sugimoto n. Drug Metab Pharmacokinet. 2024 Nov 5;60:101035. doi: 10.1016/j.dmpk.2024.101035. Online ahead of print. Drug Metab Pharmacokinet. 2024. PMID: 39693856 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,215 results

Search Page

Filters